Asia Pacific Eubiotics Market Size (2024 - 2029)

The Asia-Pacific eubiotics market is experiencing growth driven by the development of research programs by both local and global players. The increasing awareness of the nutritional benefits of probiotics, particularly their effectiveness in enhancing growth rates in broilers compared to traditional alternatives, is contributing to the expansion of the market. This trend is expected to continue over the forecast period, as the market size expands in response to these developments.

Market Size of Asia Pacific Eubiotics Industry

Asia Pacific Eubiotics Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Market Size (2024) USD 1.89 Billion
Market Size (2029) USD 2.77 Billion
CAGR (2024 - 2029) 8.00 %
Market Concentration High

Major Players

Asia Pacific Eubiotics Market Major Players

*Disclaimer: Major Players sorted in no particular order

Asia Pacific Eubiotics Market Analysis

The Asia Pacific Eubiotics Market size is estimated at USD 1.89 billion in 2024, and is expected to reach USD 2.77 billion by 2029, at a CAGR of 8% during the forecast period (2024-2029).

Eubiotics play a vital role in enhancing animal health, immunity, and overall well-being. This has led to increased demand for eubiotics to improve animal productivity and reduce mortality rates. Furthermore, the ban on Antibiotic Growth Promoters in animal feed is driving the adoption of eubiotics as an alternative in the livestock and poultry industries. In 2023, the World Organisation for Animal Health (WOAH) urged its members to limit antimicrobial use to veterinary medical purposes and to engage in discussions with relevant stakeholders to implement a complete ban on antimicrobials as growth promoters.

The increasing population and rising income levels in countries like India are fueling the demand for meat and animal products, consequently driving the need for quality animal nutrition and eubiotics. According to Invest India, India ranks as the 5th largest meat producer globally, with a production of 9.77 million metric tons in 2022-2023, representing a 5.13% increase from the previous financial year. Furthermore, advancements in eubiotics formulations and delivery methods, particularly through precision nutrition, have enhanced their effectiveness, promoting wider adoption in the market.

Asia Pacific Eubiotics Industry Segmentation

Feed eubiotics are commercially manufactured feed additives used to enhance livestock performance metrics such as weight gain, feed conversion ratio, and feed intake when administered in appropriate proportions. This study focuses solely on feed eubiotics incorporated into commercial compound feed production. The market is segmented by type (probiotics, prebiotics, organic acids, and essential oils) and by geography (China, India, Indonesia, Thailand, Japan, South Korea, Australia, and Rest of Asia-Pacific).

Type
Probiotics
Lactobacilli
Bifidobacteria
Other Probiotics
Prebiotics
Inulin
Fructo-Oligosaccharides
Galacto-Oligosaccharides
Other Prebiotics
Organic Acids
Essential Oils
Geography
Asia-Pacific
China
India
Indonesia
Thailand
Japan
South Korea
Australia
Rest of Asia-Pacific
Need A Different Region Or Segment?
Customize Now

Asia Pacific Eubiotics Market Size Summary

The Asia-Pacific Eubiotics market is experiencing significant growth, driven by increased research and development efforts from both local and global players. Key companies such as Provita Eurotech Ltd, Life Products, Inc., Calpis Co. Ltd, Chr. Hansen A/S, and Lallemand, Inc. are at the forefront of this expansion. The market is benefiting from the growing awareness of the nutritional advantages of probiotics, particularly in enhancing the growth rate in broilers compared to traditional alternatives like avilamycin and phytochemicals. Yeast probiotic supplements are gaining attention for their role in improving gut functions and reducing treatment costs in livestock farming. Field trials have demonstrated the positive impact of these probiotics on cattle and swine, highlighting their potential as sustainable alternatives to antibiotics.

China plays a pivotal role in the Asia-Pacific Eubiotics market, contributing a substantial revenue share, particularly in the aquaculture sector. The country's focus on probiotics, especially Lactobacillus, is evident in its thriving aquafeed industry. However, challenges such as the African Swine Fever have impacted pig herds, leading to a shortfall in swine feed. Despite these challenges, the market is characterized by strong R&D investments and strict regulatory norms, which are expected to further propel the Eubiotics market. The market is highly fragmented, with leaders like Chr. Hansen A/S and DuPont de Nemours Inc. offering a diverse range of products across various animal sectors, providing them with a competitive edge.

Explore More

Asia Pacific Eubiotics Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rapid Growth of the Livestock and Aquaculture Industry

      2. 1.2.2 Increasing Focus on Animal Health and Welfare

      3. 1.2.3 Rising Demand For Sustainable and Natural Feed Additives

    3. 1.3 Market Restraints

      1. 1.3.1 Lack of Standardization and Regulatory Challenges

      2. 1.3.2 High Cost of Production is Limiting the Market

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Powers of Buyers

      2. 1.4.2 Bargaining Powers of Suppliers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitutes

      5. 1.4.5 Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 Type

      1. 2.1.1 Probiotics

        1. 2.1.1.1 Lactobacilli

        2. 2.1.1.2 Bifidobacteria

        3. 2.1.1.3 Other Probiotics

      2. 2.1.2 Prebiotics

        1. 2.1.2.1 Inulin

        2. 2.1.2.2 Fructo-Oligosaccharides

        3. 2.1.2.3 Galacto-Oligosaccharides

        4. 2.1.2.4 Other Prebiotics

      3. 2.1.3 Organic Acids

      4. 2.1.4 Essential Oils

    2. 2.2 Geography

      1. 2.2.1 Asia-Pacific

        1. 2.2.1.1 China

        2. 2.2.1.2 India

        3. 2.2.1.3 Indonesia

        4. 2.2.1.4 Thailand

        5. 2.2.1.5 Japan

        6. 2.2.1.6 South Korea

        7. 2.2.1.7 Australia

        8. 2.2.1.8 Rest of Asia-Pacific

Asia Pacific Eubiotics Market Size FAQs

The Asia Pacific Eubiotics Market size is expected to reach USD 1.89 billion in 2024 and grow at a CAGR of 8% to reach USD 2.77 billion by 2029.

In 2024, the Asia Pacific Eubiotics Market size is expected to reach USD 1.89 billion.

Asia Pacific Eubiotics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)